Novel nanoparticles for cancer treatment

Cancer is one of leading causes of death worldwide to date. In 2020, nearly 10 million deaths caused by cancers were reported. For the treatment of cancers, current strategies include removing the primary tumor by surgery or inhibiting the growth of the cancer by chemotherapy, radiation therapy, and antibody-targeted therapy. Recently, nanotechnology has been extensively exploited for cancer treatment. Compared to conventional drugs, nanoparticle agents have several specific advantages, such as precise targeting, enhanced efficiency, improved biocompatibility and stability. This Research Topic aims to collect articles that developed encouraging progresses for novel nanoparticle agents that specifically target cancer cells for cancer treatment. This collection welcomes Original Research, Review, Mini Review, and Perspectives on the cancer treatment. Areas of interest could include, but not limited to: • Development of novel nanoparticle agents for cancer treatment. • Using nanoparticle to deliver small molecule drugs to cancer cells. • DNA or RNA nanoparticles to regulate the gene expression of target proteins.

Submission deadline: 22/06/2024